Michelle Bruno, MS, CQA, CMQ_OE, is currently the Director of Quality Control at AstraZeneca, specializing in Cell and Gene Therapy. They previously held several roles in quality assurance and scientific research, including Associate Director of Quality Control at Lentigen Technologies and QA/GMP Manager at Vanda Pharmaceuticals. Michelle's background includes significant experience in managing quality systems, conducting audits, and overseeing regulatory compliance throughout their diverse career in the biopharmaceutical industry. They earned a BA in Biology from Goucher College and an MS in Biology from Towson University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices